Iridex (IRIX) Cash from Investing Activities Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -40.94% |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | -32.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -32.93% |
| Jan 3, 2026 | -8.49% |
| Sep 27, 2025 | 38.90% |
| Jun 28, 2025 | 52.33% |
| Mar 29, 2025 | 24.93% |
| Dec 28, 2024 | 88.20% |
| Mar 30, 2024 | 91.79% |
| Sep 30, 2023 | -154.07% |
| Jul 1, 2023 | -13.30% |
| Apr 1, 2023 | 14.17% |
| Dec 31, 2022 | -7.94% |
| Oct 1, 2022 | 24.61% |
| Jul 2, 2022 | 6.54% |
| Apr 2, 2022 | 45.77% |
| Jan 1, 2022 | -244.36% |
| Apr 3, 2021 | -145.51% |
| Sep 26, 2020 | 51.93% |
| Jun 27, 2020 | 61.25% |
| Mar 28, 2020 | 45.71% |
| Dec 28, 2019 | 43.35% |
| Sep 28, 2019 | 37.62% |
| Jun 29, 2019 | 26.62% |
| Mar 30, 2019 | 4.13% |
| Dec 29, 2018 | 33.95% |
| Mar 31, 2018 | 9.45% |
| Sep 30, 2017 | 41.52% |
| Jul 1, 2017 | 22.50% |
| Apr 1, 2017 | -28.14% |
| Dec 31, 2016 | -14.63% |
| Oct 1, 2016 | -29.56% |
| Jul 2, 2016 | -30.08% |
| Apr 2, 2016 | -22.35% |
| Jan 2, 2016 | -39.58% |
| Apr 4, 2015 | -33.54% |
| Sep 27, 2014 | -7.92% |
| Mar 29, 2014 | -77.70% |